Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human Remove Human filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Withdrawn applications Remove Withdrawn applications filter Orphan designations Remove Orphan designations filter Referrals Remove Referrals filter European public assessment reports (EPAR) (134) Apply European public assessment reports (EPAR) filter Summaries of opinion (2) Apply Summaries of opinion filter Paediatric investigation plans (41) Apply Paediatric investigation plans filter Direct healthcare professional communication (1) Apply Direct healthcare professional communication filter

Product number

Withdrawal type

Initial authorisation (4) Apply Initial authorisation filter

Withdrawal date

From:

To:

Orphan designation – intended use

Decision date

From:

To:

Orphan decision number

Orphan designation status

Positive (21) Apply Positive filter

Referral name

Referral status

European Commission final decision (3) Apply European Commission final decision filter

Referral safety status

Yes (1) Apply Yes filter

Referral type

Article 20 procedures (3) Apply Article 20 procedures filter

Referral reference number

Referral decision making model

PRAC-CAT-CHMP-EC (1) Apply PRAC-CAT-CHMP-EC filter PRAC-CHMP-EC (1) Apply PRAC-CHMP-EC filter

Referral authorisation model

Centrally authorised product(s) (3) Apply Centrally authorised product(s) filter

Referral PRAC recommendation

Risk minimisation measures (2) Apply Risk minimisation measures filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Date of opinion

From:

To:

Medicine type

Accelerated assessment Remove Accelerated assessment filter Biosimilar Remove Biosimilar filter Additional monitoring (143) Apply Additional monitoring filter Conditional approval (37) Apply Conditional approval filter Exceptional circumstances (25) Apply Exceptional circumstances filter Generic (29) Apply Generic filter Orphan medicine (308) Apply Orphan medicine filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

28 results

Remove all filtersRemove all filters

Medicine type Accelerated assessment Remove Accelerated assessment filter Biosimilar Remove Biosimilar filter

Medicine Withdrawn applications Remove Withdrawn applications filter Orphan designations Remove Orphan designations filter Referrals Remove Referrals filter

Categories Human Remove Human filter

Sort by

List item

Orphan designation: carfilzomib for: Treatment of multiple myeloma

Date of designation: 03/06/2008, Positive, Last updated: 02/12/2015
List item

Orphan designation: Benzamide, 3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl] (ponatinib) for: Treatment of chronic myeloid leukaemia

Date of designation: 02/02/2010, Positive, Last updated: 23/03/2015
List item

Orphan designation: Benzamide, 3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl] (ponatinib) for: Treatment of acute lymphoblastic leukaemia

Date of designation: 02/02/2010, Positive, Last updated: 23/03/2015

28 results

Orphan designation: carfilzomib for: Treatment of multiple myeloma

Orphan designation: Benzamide, 3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl] (ponatinib) for: Treatment of chronic myeloid leukaemia

Orphan designation: Benzamide, 3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl] (ponatinib) for: Treatment of acute lymphoblastic leukaemia